Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06716372Not ApplicableCompleted

A Clinical Trial to Evaluate the Vision Correction Safety and Efficacy of DSiHy Silicone Hydrogel Soft Contact Lens

Role: lead

NCT06716385Not ApplicableCompleted

A Clinical Trial to Evaluate the Vision Correction Safety and Efficacy of MSiHy Silicone Hydrogel Soft Contact Lens

Role: lead

NCT03934788Not ApplicableCompleted

the Clinical Performance of the Oxysoft Daily Disposable Silicone Hydrogel Soft Contact Lens

Role: lead

NCT03139201Not ApplicableCompleted

Clinical Performance of the OxyAqua Daily Disposable Silicone Hydrogel Soft Contact Lens

Role: lead

NCT02354924Not ApplicableCompleted

Clinical Evaluation of Two Daily Wear Silicon Hydrogel Contact Lens

Role: lead

NCT02676258Not ApplicableCompleted

Clinical Comparison of Two Daily Disposable Silicone Hydrogel Soft Contact Lens

Role: lead

All 6 trials loaded